All In MedTech

FDA Clearance Tracker · P180002-S009

Zephyr Valve Registry (ZEVR)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 2, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 2, 2019

Approved

Time to decision

58 days

Received Aug 5, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P180002-S009
Device name
Zephyr Valve Registry (ZEVR)
Applicant location
Redwood City, CA
Received
Aug 5, 2019
Decided
Oct 2, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P180002

Device type

Device class
Class III

Every decision under product code NJK

FDA's approval statement

As written in FDA's record.

Approval for the enrollment of at least 20 patients with the new sized Zephyr valve (5.5 LP EBV).

Source documents

Other decisions for Pulmonx Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.